Cargando…
Peptides as Potential Therapeutics for Alzheimer’s Disease
Intracellular synthesis, folding, trafficking and degradation of proteins are controlled and integrated by proteostasis. The frequency of protein misfolding disorders in the human population, e.g., in Alzheimer’s disease (AD), is increasing due to the aging population. AD treatment options are limit...
Autor principal: | Ribarič, Samo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017258/ https://www.ncbi.nlm.nih.gov/pubmed/29385735 http://dx.doi.org/10.3390/molecules23020283 |
Ejemplares similares
-
Physical Exercise, a Potential Non-Pharmacological Intervention for Attenuating Neuroinflammation and Cognitive Decline in Alzheimer’s Disease Patients
por: Ribarič, Samo
Publicado: (2022) -
The Rationale for Insulin Therapy in Alzheimer’s Disease
por: Ribarič, Samo
Publicado: (2016) -
Nanotechnology Therapy for Alzheimer′s Disease Memory Impairment Attenuation
por: Ribarič, Samo
Publicado: (2021) -
Detecting Early Cognitive Decline in Alzheimer’s Disease with Brain Synaptic Structural and Functional Evaluation
por: Ribarič, Samo
Publicado: (2023) -
Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
por: Milisav, Irina, et al.
Publicado: (2015)